Tessa J J de Bitter

8PUBLICATIONS
26CO-AUTHORS
Liquid biopsiesHaematological tumoursImmunogenetics (incl. genetic immunology)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 19, 2025
Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands.

Tessa J J de Bitter, Maartje J Geerlings, Leonie I Kroeze

|Jul 09, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Stefan G van Ravensteijn, Jacco J de Haan, Hans Gelderblom

|Dec 11, 2022
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Stefan G van Ravensteijn, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen

|Nov 06, 2022
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Tessa J J de Bitter, Philip R de Reuver, Elise A J de Savornin Lohman

|Nov 13, 2021
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.

Hendrien Kuipers, Tessa J J de Bitter, Marieke T de Boer

|Jul 02, 2021
Quality Assessment of Gallbladder Cancer Pathology Reports: A Dutch Nationwide Study.

Tessa J J de Bitter, Elise A J de Savornin-Lohman, Philip R de Reuver

Pageof 2

Frequent Collaborators

2 joint publications

Marjolijn J L Ligtenberg

2 joint publications

Stefanus G van Ravensteijn

2 joint publications

Yvonne M H Versleijen-Jonkers

2 joint publications

Mark A J Gorris